Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer

  Free Subscription


14.04.2025

1 Acta Biochim Biophys Sin (Shanghai)
1 Acta Obstet Gynecol Scand
1 Afr Health Sci
1 Am J Epidemiol
1 Ann Med Surg (Lond)
1 Biomark Med
1 Biometrics
1 BMC Cancer
1 BMC Glob Public Health
1 BMC Infect Dis
2 BMC Public Health
1 BMC Womens Health
1 Bull Cancer
2 Cancer Control
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Gene Ther
1 Cancer Med
1 Cancer Treat Rev
1 Comput Biol Med
1 Contraception
1 Cult Health Sex
1 Curr Top Med Chem
1 Cytokine
1 Cytopathology
1 Discov Oncol
1 Ear Nose Throat J
1 Eur J Histochem
1 Eur J Med Res
1 Eur J Pharm Biopharm
1 Eur J Public Health
1 Eur J Surg Oncol
2 Front Oncol
1 Geburtshilfe Frauenheilkd
1 Gene
1 Ginekol Pol
1 Hereditas
1 Hum Vaccin Immunother
1 Indian J Public Health
1 Int J Biol Macromol
1 Int J Clin Oncol
1 Int J Gynaecol Obstet
2 Int J Gynecol Cancer
1 J Cancer Educ
4 J Cancer Res Ther
1 J Cell Mol Med
1 J Epidemiol Community Health
1 J Med Virol
1 J Natl Cancer Inst
1 J Obstet Gynaecol
1 J Transl Med
1 JCO Glob Oncol
1 Malawi Med J
1 Med Oncol
1 Medicina (B Aires)
1 Medicine (Baltimore)
1 Nat Commun
1 Naunyn Schmiedebergs Arch Pharmacol
1 Oncol Res
1 Patient Educ Couns
1 Pilot Feasibility Stud
1 Reprod Sci
2 Sci Rep


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Biochim Biophys Sin (Shanghai)

  1. CHEN T, Xu Y, Yang K, Du Y, et al
    Withaferin A combined with ricolinostat: a potent synergistic therapy for cervical cancer through regulating p53 ubiquitination and acetylation.
    Acta Biochim Biophys Sin (Shanghai). 2025 Apr 10. doi: 10.3724/abbs.2025048.
    PubMed        


    Acta Obstet Gynecol Scand

  2. SUNDQVIST A, Hellsten C, Strander B, Lindh M, et al
    Self-collected vaginal HPV samples for long-term non-attendees in the Swedish organized cervical cancer screening program.
    Acta Obstet Gynecol Scand. 2025 Apr 7. doi: 10.1111/aogs.15112.
    PubMed         Abstract available


    Afr Health Sci

  3. GETINET M
    Oncogenic human papillomavirus infection (HPV 16/18) and associated factors among women in East Gojjam Zone, NorthWest Ethiopia 2021.
    Afr Health Sci. 2024;24:9-19.
    PubMed         Abstract available


    Am J Epidemiol

  4. BUKOWSKI A, Hoyo C, Graff M, Vielot NA, et al
    Epigenome-wide differential methylation and differential variability as predictors of high-grade cervical intraepithelial neoplasia (CIN2+).
    Am J Epidemiol. 2025;194:1012-1022.
    PubMed         Abstract available


    Ann Med Surg (Lond)

  5. QAMAR J, Maheen M, Mohammad JG
    Insufficient resources for cervical cancer in Pakistan: a significant burden on public health.
    Ann Med Surg (Lond). 2025;87:1114-1116.
    PubMed        


    Biomark Med

  6. ZHANG Y, Li B, Li J, Zhao J, et al
    NDRG1/2 as a prognostic predictive biomarker of cervical cancer and its correlation with immune infiltration.
    Biomark Med. 2025 Apr 7:1-11. doi: 10.1080/17520363.2025.2483495.
    PubMed         Abstract available


    Biometrics

  7. NIKOLOULOPOULOS AK
    Vine copula mixed models for meta-analysis of diagnostic accuracy studies without a gold standard.
    Biometrics. 2025;81:ujaf037.
    PubMed         Abstract available


    BMC Cancer

  8. GE Y, Wu F, Zhang Y, Wang X, et al
    Prevalence of HPV infection and cervical lesions among women with pelvic organ prolapse and implications for preoperative evaluation.
    BMC Cancer. 2025;25:624.
    PubMed         Abstract available


    BMC Glob Public Health

  9. NESSA A, Azad AK, Uddin SMN, Khan MAH, et al
    Cervical cancer screening data from the case-based national electronic registry in Bangladesh.
    BMC Glob Public Health. 2025;3:34.
    PubMed         Abstract available


    BMC Infect Dis

  10. HADDISON EC, Engoung DB, Bodo CB, Njie VM, et al
    Overcoming HPV vaccine hesitancy: insights from a successful school-based vaccination campaign in the Saa health district of Cameroon.
    BMC Infect Dis. 2025;25:465.
    PubMed         Abstract available


    BMC Public Health

  11. CHABALALA TV, Maimela E, Mashaba RG, Ntimana CB, et al
    Factors that contribute to women's reluctance to undergo cervical cancer screening in clinics of Limpopo Province, South Africa.
    BMC Public Health. 2025;25:1303.
    PubMed         Abstract available

  12. MORALES-CAMPOS DY, Adsul P, Liang Y, Donovan E, et al
    Trusted health system implementation strategies to increase vaccination (TRUE SYNERGI): a stepped-wedge cluster randomized trial to reduce HPV-related cancers.
    BMC Public Health. 2025;25:1331.
    PubMed         Abstract available


    BMC Womens Health

  13. AJAH MI, Dibua MEU, Ajah LO, Chigor NV, et al
    Exploring the role of cervicovaginal microbiota as risk factor for cervical cancer in Sub-Saharan Africa: a systematic review and meta-analysis : By.
    BMC Womens Health. 2025;25:160.
    PubMed         Abstract available


    Bull Cancer

  14. TURPIN A, Tran PL, Encaoua J, Khettab M, et al
    [Cancer of the cervix management in Reunion Island from 2016 to 2020].
    Bull Cancer. 2025;112:396-402.
    PubMed         Abstract available


    Cancer Control

  15. HAITH L, Deaney C, Reesby D, Ellis V, et al
    A Retrospective Observational Study on the Impact of Digital Strategies to Boost Cervical Screening Uptake in Primary Care.
    Cancer Control. 2025;32:10732748251330705.
    PubMed         Abstract available

  16. TAUMBERGER N, Friko I, Der VM, Ellis LB, et al
    Implementing High-Risk Human Papillomavirus Self-Sampling for Cervical Cancer Screening in Ghana: A Study (CarciSCAN) Protocol.
    Cancer Control. 2025;32:10732748251330698.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  17. BIEDERMAN EB, Stump TE, Monahan PO, Katz ML, et al
    A Randomized Control Trial of Two Interventions Compared to Usual Care for Increasing Cervical Cancer Screening Among Women Living in the Rural Midwest.
    Cancer Epidemiol Biomarkers Prev. 2025 Apr 8. doi: 10.1158/1055-9965.EPI-24-0971
    PubMed         Abstract available


    Cancer Gene Ther

  18. KANDURI M, Subhash S, Putino R, Mahale S, et al
    IER3: exploring its dual function as an oncogene and tumor suppressor.
    Cancer Gene Ther. 2025;32:450-463.
    PubMed         Abstract available


    Cancer Med

  19. CHEN H, Guo K, Bai Z, Lu L, et al
    Advances in the Prevention of Cervical Cancer by Anti-Human Papillomavirus Agents.
    Cancer Med. 2025;14:e70847.
    PubMed         Abstract available


    Cancer Treat Rev

  20. PETRELLI F, Riboldi V, Bruschieri L, Villa A, et al
    First-line treatment of locally advanced cervical carcinoma: An updated systematic review and Bayesian network meta-analysis.
    Cancer Treat Rev. 2025;135:102921.
    PubMed         Abstract available


    Comput Biol Med

  21. BANO N, Ahmad S, Gupta D, Raza K, et al
    FDA-approved Levophed as an alternative multitargeted therapeutic against cervical cancer transferase, cell cycle, and regulatory proteins.
    Comput Biol Med. 2025;191:110163.
    PubMed         Abstract available


    Contraception

  22. BATUR P, Brant A, McCourt C, Schwarz EB, et al
    Society of Family Planning Clinical Recommendation: Contraceptive considerations for individuals with cancer and cancer survivors part 2 - Breast, ovarian, uterine, and cervical cancer.
    Contraception. 2025 Mar 27:110867. doi: 10.1016/j.contraception.2025.110867.
    PubMed         Abstract available


    Cult Health Sex

  23. BENNETT LR, Astari P
    Unpacking cervical cancer stigma in healthcare: lessons learnt from Indonesian patients and health professionals.
    Cult Health Sex. 2025 Apr 11:1-16. doi: 10.1080/13691058.2025.2488036.
    PubMed         Abstract available


    Curr Top Med Chem

  24. SOUZA APO, de Lima LA, Ferreira PAB, Dutra RF, et al
    Advances in Cervical Cancer Diagnostics Based on Immunosensors: Innovative Approaches and Tumor Biomarkers.
    Curr Top Med Chem. 2025 Apr 4. doi: 10.2174/0115680266366335250314081522.
    PubMed         Abstract available


    Cytokine

  25. REN J, Xie L, Zhu X, Chen X, et al
    Resveratrol interrupts Wnt/beta-catenin signalling in cervical cancer by activating ten-eleven translocation 5-methylcytosine dioxygenase 1.
    Cytokine. 2025;190:156930.
    PubMed         Abstract available


    Cytopathology

  26. GERHARD R, Colmenarez CR, Selle C, Hammer GP, et al
    Digital Cytology Combined With Artificial Intelligence Compared to Conventional Microscopy for Anal Cytology: A Preliminary Study.
    Cytopathology. 2025;36:250-258.
    PubMed         Abstract available


    Discov Oncol

  27. CHEN L, Liu W, Wang M, Feng Y, et al
    Expression of REV7 has prognostic significance in cervical cancer treated with intensity-modulated radiation therapy.
    Discov Oncol. 2025;16:466.
    PubMed         Abstract available


    Ear Nose Throat J

  28. LI S, Tang J, Wang J, Liu X, et al
    Metastasis of Mixed Adenoneuroendocrine Carcinoma of the Uterine Cervix to Thyroid Gland.
    Ear Nose Throat J. 2025;104.
    PubMed         Abstract available


    Eur J Histochem

  29. WU X, Lin K, Gao C, Ni Y, et al
    miR-627-5p inhibits malignant progression of cervical cancer by targeting ANGPTL4.
    Eur J Histochem. 2025;69.
    PubMed         Abstract available


    Eur J Med Res

  30. BAO Q, Tang W, Tang W, Zhu X, et al
    Identification of immune-related cervical cancer prognostic biomarkers and construction of prognostic model based on tumor microenvironment.
    Eur J Med Res. 2025;30:261.
    PubMed         Abstract available


    Eur J Pharm Biopharm

  31. LOPES-NUNES J, Lopes M, Rosado B, Maocha IG, et al
    Vaginal formulation development: A strategy based on aptamer-guided liposome for human papillomavirus-induced lesions.
    Eur J Pharm Biopharm. 2025;210:114693.
    PubMed         Abstract available


    Eur J Public Health

  32. JAWOREK H, Bouska O, Kourilova P, Hajduch M, et al
    High-risk HPV prevalence in the Czech cervical cancer screening population: a comparison of clinician-collected and self-collected sampling.
    Eur J Public Health. 2025 Apr 7:ckaf045. doi: 10.1093.
    PubMed         Abstract available


    Eur J Surg Oncol

  33. BIZZARRI N, Schivardi G, Di Martino G, Antonacci A, et al
    Factors associated with bilateral sentinel lymph node mapping failure using indocyanine green in patients with apparent early-stage cervical cancer: An Italian retrospective multi-center study.
    Eur J Surg Oncol. 2025;51:109981.
    PubMed         Abstract available


    Front Oncol

  34. XU Z, Wang M, Gong L, Luo G, et al
    Promising outcomes of the PD-L1 inhibitor Socazolimab in recurrent and metastatic cervical cancer: a case report.
    Front Oncol. 2025;15:1541760.
    PubMed         Abstract available

  35. SUN S, Gong X, Liang Y, Sun Y, et al
    Evaluating the Implementation of fan-beam CT-guided online adaptive re-planning in definitive cervical cancer radiotherapy.
    Front Oncol. 2025;15:1509619.
    PubMed         Abstract available


    Geburtshilfe Frauenheilkd

  36. HELLFRITSCH J, Panzer M, Wagner S, Nieschke K, et al
    First Results for the Evaluation of the Cervical Cancer Screening Carried Out in 2021 and 2022 in the Context of the Organized Cancer Screening Program (oKFE): Part 1 - Primary Screening.
    Geburtshilfe Frauenheilkd. 2025;85:417-433.
    PubMed         Abstract available


    Gene

  37. VAN DER MERWE M, Myburgh K, Garnis C, Towle R, et al
    Unravelling the role of extracellular vesicles in cervical cancer: Mechanisms of progression, resistance, and emerging therapeutic strategies.
    Gene. 2025 Apr 7:149467. doi: 10.1016/j.gene.2025.149467.
    PubMed         Abstract available


    Ginekol Pol

  38. MISZCZYK K, Keczkowska E, Ciebiera M
    Cervical screening during pregnancy - a review of recommendations.
    Ginekol Pol. 2025;96:220-224.
    PubMed         Abstract available


    Hereditas

  39. LIU J, Han B, Hu X, Yuan M, et al
    Identification of N6-methyladenosine-associated ferroptosis biomarkers in cervical cancer.
    Hereditas. 2025;162:53.
    PubMed         Abstract available


    Hum Vaccin Immunother

  40. CHOI W, Shim E
    The effects of human papillomavirus vaccination in Japan.
    Hum Vaccin Immunother. 2025;21:2489301.
    PubMed         Abstract available


    Indian J Public Health

  41. DIAZ-VALLEJO JJ, Lagunes-Baez E, Cordoba-Colorado D, Perez-Vasquez MO, et al
    Determination of Human Papillomavirus Serotypes in Endocervical Samples from Patients with Normal Cytology from a Mexican Population by Polymerase Chain Reaction-restriction Fragment Length Polymorphism.
    Indian J Public Health. 2025;69:115-118.
    PubMed         Abstract available


    Int J Biol Macromol

  42. ZHU ZM, Huo FC, Shi C, Li MT, et al
    METTL3-mediated m6A modification of PAK6 drives cervical cancer progression through activating MAPK14.
    Int J Biol Macromol. 2025;309.
    PubMed         Abstract available


    Int J Clin Oncol

  43. MATSUMURA N, Mandai M
    PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of amivantamab plus lazertinib for non-small cell lung cancer, durvalumab for small cell lung cancer, tislelizumab for esophageal cancer, tisotuma
    Int J Clin Oncol. 2025 Apr 11. doi: 10.1007/s10147-025-02758.
    PubMed        


    Int J Gynaecol Obstet

  44. FUSEINI NM, El Joueidi S, Montgomery T, Lemrabott E, et al
    Cervical precancer screening and treatment in Nouakchott, Mauritania: Pilot program to inform development of Mauritania's national cervical cancer prevention program.
    Int J Gynaecol Obstet. 2025 Apr 11. doi: 10.1002/ijgo.70145.
    PubMed        


    Int J Gynecol Cancer

  45. LEITAO MM JR, Bixel KL, Chase DM, Quick A, et al
    ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer.
    Int J Gynecol Cancer. 2025 Feb 28:101760. doi: 10.1016/j.ijgc.2025.101760.
    PubMed         Abstract available

  46. LIAO J, Xu T, Zhou J, Xiao N, et al
    The impact of chemotherapy on survival in patients aged >/=65 years with locoregionally cervical cancer who undergo radiotherapy: a Surveillance, Epidemiology, and End Results database analysis.
    Int J Gynecol Cancer. 2025 Mar 3:101747. doi: 10.1016/j.ijgc.2025.101747.
    PubMed         Abstract available


    J Cancer Educ

  47. JOE TR, Natonie KM, Charley KR, Lee NR, et al
    Increasing HPV and Cervical Cancer Education Among Native American Communities and Healthcare Providers.
    J Cancer Educ. 2025 Apr 10. doi: 10.1007/s13187-025-02619.
    PubMed         Abstract available


    J Cancer Res Ther

  48. KUMAR W, Lohia S, Agrawal A, Yadav V, et al
    A rare case of synchronous cervical squamous cell carcinoma and invasive ductal carcinoma of breast.
    J Cancer Res Ther. 2025;21:281-283.
    PubMed         Abstract available

  49. GOYAL LD, Garg P, Kankaria A, Kaur N, et al
    The current status of cervical cancer awareness and HPV Vaccination among rural women of India: An impediment to the WHO cervical cancer elimination initiative.
    J Cancer Res Ther. 2025;21:57-63.
    PubMed         Abstract available

  50. SARAWAGI R, Sharma DN, Kumar R, Subramani V, et al
    Positron emission tomography versus computed tomography -guided intracavitary brachytherapy for locally advanced cervical cancer: A prospective randomized study.
    J Cancer Res Ther. 2025;21:151-155.
    PubMed         Abstract available

  51. BHARTI JN
    Adenoid basal carcinoma cervix - A rare epithelial neoplasm.
    J Cancer Res Ther. 2025;21:226-229.
    PubMed         Abstract available


    J Cell Mol Med

  52. ZHAO Z, Peng Y, Yang Y, Li S, et al
    ATP13A2 as a prognostic biomarker and its correlation with immune infiltration in cervical cancer: A retrospective study.
    J Cell Mol Med. 2025;29:e70097.
    PubMed         Abstract available


    J Epidemiol Community Health

  53. DEMA E, Osman R, Soldan K, Field N, et al
    Are there any sociodemographic factors associated with non-uptake of HPV vaccination of girls in high-income countries with school-based vaccination programmes? A systematic review.
    J Epidemiol Community Health. 2025;79:388-396.
    PubMed         Abstract available


    J Med Virol

  54. ULARNWONG M, Hanamornroongruang S, Ruengkhachorn I, Karnchanabanyong W, et al
    Diagnostic Accuracy of the Siriraj Portable Digital Cervicography Device Versus Standard Colposcopy for Detecting CIN2(+) Lesions.
    J Med Virol. 2025;97:e70339.
    PubMed         Abstract available


    J Natl Cancer Inst

  55. RAMIREZ AT, Mesher D, Baena A, Salgado Y, et al
    Impact of knowledge of HPV positivity on cervical cytology performance in latin america.
    J Natl Cancer Inst. 2024 Nov 12:djae283. doi: 10.1093.
    PubMed         Abstract available


    J Obstet Gynaecol

  56. HU X, Wang Y, Guo H, Guo Y, et al
    The long noncoding RNA CCDC144NL-AS1: prognosis significance and potential biological functions in cervical carcinoma.
    J Obstet Gynaecol. 2025;45:2463416.
    PubMed         Abstract available


    J Transl Med

  57. SUN H, Zhang Y, Wang F, Wang Z, et al
    SORBS3-beta suppresses lymph node metastasis in cervical cancer by promoting the ubiquitination of beta-catenin.
    J Transl Med. 2025;23:406.
    PubMed         Abstract available


    JCO Glob Oncol

  58. WEXLER C, Maloba M, Mabachi N, Maosa N, et al
    Availability and Uptake of Cervical Cancer Screening and Treatment Services at 19 Kenyan Health Facilities: A Brief Report.
    JCO Glob Oncol. 2025;11:e2400255.
    PubMed         Abstract available


    Malawi Med J

  59. PANKAJ S, Rani J, Kumari P, Abhilashi K, et al
    Efficacy of HPV E6/E7 mRNA assay, HPV DNA test and cytology in detection of high grade cervical lesions and invasive cancer at a tertiary care center in India.
    Malawi Med J. 2024;36:120-127.
    PubMed         Abstract available


    Med Oncol

  60. YOUNAS S, Nosheen A, Malik ZI, Hussain N, et al
    Genetic analysis of HPV-16 L1 gene mutations and computational screening of therapeutic inhibitors for cervical cancer treatment.
    Med Oncol. 2025;42:153.
    PubMed         Abstract available


    Medicina (B Aires)

  61. AUTHIER CIPOLLA EC, Tourinan MR, Lamonica CB, Bazzi AR, et al
    [Ectopic ACTH secretion by neuroendocrine carcinoma of the uterine cervix].
    Medicina (B Aires). 2025;85:439-444.
    PubMed         Abstract available


    Medicine (Baltimore)

  62. SHAO D, Yu H, Zhu X
    Screening and identification analysis of core markers for leukemia and cervical cancer: Calmodulin 3 as a core target.
    Medicine (Baltimore). 2025;104:e41665.
    PubMed         Abstract available


    Nat Commun

  63. XING H, Sun R, Ren J, Wei J, et al
    Achieving flexible fairness metrics in federated medical imaging.
    Nat Commun. 2025;16:3342.
    PubMed         Abstract available


    Naunyn Schmiedebergs Arch Pharmacol

  64. WANG B, Zhang Q, Wang L, Su H, et al
    ADAMDEC1 promotes cervical squamous cell carcinoma by enhancing the JAK/STAT signaling pathway through modulation of TYMP.
    Naunyn Schmiedebergs Arch Pharmacol. 2025;398:6009-6020.
    PubMed         Abstract available


    Oncol Res

  65. PANG G, Li Y, Shi Q, Tian J, et al
    Omics sciences for cervical cancer precision medicine from the perspective of the tumor immune microenvironment.
    Oncol Res. 2025;33:821-836.
    PubMed         Abstract available


    Patient Educ Couns

  66. ALQETHAMI A, Alhalal E
    A theory-based educational intervention to increase mothers' intention to vaccinate their daughters against human papillomavirus: A randomised controlled trial.
    Patient Educ Couns. 2025;135:108731.
    PubMed         Abstract available


    Pilot Feasibility Stud

  67. MILLET N, McDermott HJ, Munir F, Edwardson CL, et al
    The feasibility and acceptability of delivering and evaluating a physical activity intervention (ACCEPTANCE) for cervical cancer survivors.
    Pilot Feasibility Stud. 2025;11:42.
    PubMed         Abstract available


    Reprod Sci

  68. DENG E, Gu Z, Wei H, Liu C, et al
    Using Machine Learning to Predict the Prognosis of Cervical Cancer Patients with Lymph Node Metastasis: An Analysis Based on the SEER Database.
    Reprod Sci. 2025 Apr 7. doi: 10.1007/s43032-025-01856.
    PubMed         Abstract available


    Sci Rep

  69. SEIFU BL, Negussie YM, Asnake AA, Asebe HA, et al
    Wealth-related inequalities of women's cervical cancer screening in 11 Sub-Saharan African countries: evidence from a pooled decomposition analysis.
    Sci Rep. 2025;15:12289.
    PubMed         Abstract available

  70. MENG X, Song S, Li K, Duan Y, et al
    Application of CT in predicting lymph node metastasis in cervical cancer and construction of a preoperative nomogram.
    Sci Rep. 2025;15:11674.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.